Search by Drug Name or NDC
NDC 70121-1567-01 Bleomycin 15000 [iU]/1 Details
Bleomycin 15000 [iU]/1
Bleomycin is a INTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is BLEOMYCIN SULFATE.
MedlinePlus Drug Summary
Bleomycin injection is used alone or in combination with other medications to treat head and neck cancer (including cancer of the mouth, lip, cheek, tongue, palate, throat, tonsils, and sinuses) and cancer of the penis, testicles, cervix, and vulva (the outer part of the vagina). Bleomycin is also used to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (cancer that begins in the cells of the immune system) in combination with other medications. It is also used to treat pleural effusions (a condition when fluid collects in the lungs) that are caused by cancerous tumors. Bleomycin is a type of antibiotic that is only used in cancer chemotherapy. It slows or stops the growth of cancer cells in your body.
Related Packages: 70121-1567-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bleomycin
Product Information
| NDC | 70121-1567 |
|---|---|
| Product ID | 70121-1567_1f5a11cf-7247-4659-9e50-716901d87c8f |
| Associated GPIs | |
| GCN Sequence Number | 008823 |
| GCN Sequence Number Description | bleomycin sulfate VIAL 15 UNIT INJECTION |
| HIC3 | V1D |
| HIC3 Description | ANTIBIOTIC ANTINEOPLASTICS |
| GCN | 38610 |
| HICL Sequence Number | 003918 |
| HICL Sequence Number Description | BLEOMYCIN SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Bleomycin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bleomycin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 15000 |
| Active Ingredient Units | [iU]/1 |
| Substance Name | BLEOMYCIN SULFATE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Cytoprotective Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70121-1567-01 (70121156701)
| NDC Package Code | 70121-1567-1 |
|---|---|
| Billing NDC | 70121156701 |
| Package | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (70121-1567-1) |
| Marketing Start Date | 2016-06-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |